e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Risk assessment and prevention of complications in thoracic surgery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do non-steroidal anti-inflammatory agents prevent strictural complications of tracheal surgery? The effects of tenoxicam on tracheal healing
S. Gezer, S. Karapolat, U. Yildirim (Turkey)
Source:
Annual Congress 2010 - Risk assessment and prevention of complications in thoracic surgery
Session:
Risk assessment and prevention of complications in thoracic surgery
Session type:
Oral Presentation
Number:
3664
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Gezer, S. Karapolat, U. Yildirim (Turkey). Do non-steroidal anti-inflammatory agents prevent strictural complications of tracheal surgery? The effects of tenoxicam on tracheal healing. Eur Respir J 2010; 36: Suppl. 54, 3664
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Severe haemoptysis
Related content which might interest you:
Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001
Mucolytics and anti-inflammatory lung treatments
Source: ERS course 2015
Year: 2015
Inhalations of ultra-low doses of alkylating drug for the treatment of steroid-dependant asthma: anti-inflammatory effect of therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
The effect of omalizumab on blood eosinophils count in patients with hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID) compare to patients who tolerate NSAID–pilot study
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Year: 2001
Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?
Source: Eur Respir J 2004; 24: 1-2
Year: 2004
Therapeutic effects of topical calcilytic in IgE/Th2 and alarmin-driven surrogates of human asthma
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019
Non-steroidal anti-inflammatory drug use and clinical outcomes of community-acquired pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Influence of prior nonsteroidal anti-inflammatory steroidal drugs (NSAID) on the presentation and evolution of hospitalized community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
The effect of corticosteroids on pleurodesis induced by iodopovidone in rabbits
Source: Eur Respir J 2006; 28: Suppl. 50, 650s
Year: 2006
Efficacy of low dose theophylline in patient with bronchial asthma - anti-inflammatory effect
Source: Eur Respir J 2003; 22: Suppl. 45, 102s
Year: 2003
Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
A randomized trial of AZD7594 a novel non-steroidal anti-inflammatory drug in asthma patients
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Anti-inflammatory therapies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 223-238
Year: 2011
Time to ban short-acting ß-agonists and use anti-inflammatory treatment as required to improve outcomes
Source: Virtual Congress 2021 – Wheezing illnesses along the life span
Year: 2021
Anti-inflammatory properties of nimesulide and clarithromycin: a comparative study during the therapy of bronchial sepsis involving
P.aeruginosa
Source: Eur Respir J 2002; 20: Suppl. 38, 373s
Year: 2002
Sedative medications in COVID-19 positive ARDS patients undergoing tracheostomy
Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy
Year: 2021
Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia
Source: Eur Respir J 2015; 46: 876-877
Year: 2015
Nonsteroid anti-inflammatory agents depress inflammation-related respiratory disoders and hypoxia-induced mortality. Experimental model.
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept